Biotech Case Study: Explaining Potravitug with Animation
Want to explain your science like a pro?
Before you dive into our biotech case study, start with our guide on science storytelling for biotech founders.
Biotech Case Study: What Is Potravitug?
Potravitug is a therapeutic antibody developed by Memo Therapeutics for treating BK viremia in kidney transplant patients. BK viremia is a dangerous viral reactivation that can lead to nephropathy, organ rejection, or even death.
Unlike traditional therapies, Potravitug is derived from the immune response of a transplant recipient who naturally cleared high levels of BK virus. This makes it a uniquely potent candidate—and a highly targeted solution.
Why They Needed a Video
Memo’s science is solid, but not easy to explain. When speaking to investors or preparing for a Phase III trial, clarity matters. That’s why they asked us to help turn their clinical breakthrough into a clear, visual story—one worth sharing as a biotech case study.
Biotech Case Study: Behind the Scenes
1. Fine-Tuning the Science
One of the key challenges was terminology.
The phrase “convalescent donor” risked being misinterpreted as a plasma-based therapy. In reality, Potravitug is derived from antibodies identified in a transplant patient—not plasma transfer. We worked closely with Memo to clarify this distinction visually and in the voice-overEmails from @memo-thera….
2. Visual Details Matter
At one point, Memo’s team felt the epithelial cells in a slide looked too much like a “living room rug.” That sparked a redesign: we updated the cilia texture, straightened the structure, and adjusted nucleus placement for anatomical accuracy and visual appealEmails from @memo-thera….
3. Nailing the Voice-Over
Getting the pronunciation of “Potravitug” right wasn’t trivial. The team exchanged voice notes and mp3s to ensure consistency across narration and visualsEmails from @memo-thera….
4. Getting Sign-Off and Use Cases
Once delivered, Memo shared the video with colleagues—and got positive feedback across the board. Christoph Esslinger noted it was “exactly to the point” and mentioned possible use in investor meetings and patient information materials for Phase IIIEmails from @memo-thera….
The Final Video: Simple, Strong, and Shareable
This biotech case study shows how Memo now uses the Potravitug video to:
- Explain their science to investors
- Prepare stakeholders for Phase III trials
- Spark interest and clarity in less than two minutes
And we’re proud to have played a role in making that message shine.
Final Thought
If you’re a biotech founder, you know how hard it is to make complex science resonate quickly.
This biotech case study proves that when it’s done right, a short animation can transform your communication—and your results.
👉 Learn how to communicate your science clearly to investors
